Reply to "Comment on 'Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark'"

Affiliations

¹ Department of Clinical Biochemistry and Clinical Pharmacology, Odense University Hospital, Odense, Denmark; Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark. Electronic address: sarnspang@health.sdu.dk.
² Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.

Comment

Sidsel Arnspang Pedersen et al. J Am Acad Dermatol. 2021 Dec.

. 2021 Dec;85(6):e359-e360.

doi: 10.1016/j.jaad.2019.02.019. Epub 2019 Feb 13.

¹ Department of Clinical Biochemistry and Clinical Pharmacology, Odense University Hospital, Odense, Denmark; Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark. Electronic address: sarnspang@health.sdu.dk.
² Department of Clinical Pharmacology and Pharmacy, University of Southern Denmark, Odense, Denmark.

No abstract available

Comment on

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Pedersen SA, et al. J Am Acad Dermatol. 2018 Apr;78(4):673-681.e9. doi: 10.1016/j.jaad.2017.11.042. Epub 2017 Dec 4. J Am Acad Dermatol. 2018. PMID: 29217346
Comment on "Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark".
van Veelen A, Nielen JTH, van Geel R, Croes S. van Veelen A, et al. J Am Acad Dermatol. 2021 Dec;85(6):e357. doi: 10.1016/j.jaad.2019.01.087. Epub 2019 Feb 13. J Am Acad Dermatol. 2021. PMID: 30771418 No abstract available.